Biofourmis CEO Kuldeep Singh to delve on healthcare data analytics

He will discuss this and more at the SBR Hottest Startups Panel Briefing 2017.

Kuldeep Singh is the Founder and CEO of Biofourmis Pte Ltd, a Singapore-based data analytics company working around a singular challenge: to personalise healthcare through actionable insights. An ex-PhD Research Scholar at the National University of Singapore, Singh took a break from his PhD to focus on building bioelectronics medicines which aim to control biological processes and treat diseases by modulating electric impulses.

Prior to moving to Singapore, he held a research position at MIT Media Lab’s Camera Culture group, where he worked on various wearable technologies and biosignal analytics for cardiac health monitoring. He believes in pushing out working prototypes and closing the gap between engineering and medicine. He is the part of Google’s Solve for X community and has been invited to speak at various prestigious platforms like TEDx, HiMSS, EMBC etc. on various biomedical technologies.

Singh and his team at Biofourmis have begun their journey towards unlocking the potential of biosensors to give deeper and meaningful insights into one’s health, through data. He seeks to connect ideas and people to spark innovation.

Singh will be part of the panel in the upcoming Singapore Business Review's 20 Hottest Startups Panel Briefing 2017, happening on July 11, 2017, 8:30-11:30AM at the Meeting Room 3345, Suntec Singapore Convention & Exhibition Centre.

What are your previous experiences and positions held that contributed to who you are as an entrepreneur today?

Inspired by the advancement in biosensor technology and personalised medicine, I took a break from my Doctorate Studies to build my company, as the Founder and CEO of Biofourmis, a healthcare data analytics company working around a singular challenge: to personalise healthcare. I am the inventor of Biovitals, the world’s first personalised data analytics engine based on human physiology that captures continuous stream of physiological data from bio-sensors and uses cognitive technologies towards building a sophisticated predictive analytics engine. The revolutionary health programs tackle remote, home based post-acute monitoring of cardiac patients in the most engaging, effective and personalised way possible.
I am an active member of the healthcare innovation and entrepreneurship community in Singapore, with a specific interest in technology-enabled healthcare innovation. I am also a Visiting Research Scholar at the National University of Singapore, focusing on building bioelectronics medicines, which aims to control biological processes and treat diseases by modulating electric impulses. Prior to moving to Singapore, I held a research position at MIT Media Lab’s Camera Culture group, where I worked on developing automated diagnosis and interpretation algorithms using electrical and optical biosensors for cardiac health monitoring. I believe in pushing out working prototypes and closing the gap between engineering and medicine. I started my first company at the age of 18, which built assistive technologies for hearing impaired, which was acquired by a US based NGO.
I have been invited to speak at various prestigious platforms like TED, HiMSS, EMBC, BHF and IoT Asia on my vision to transform healthcare ecosystem using biosensor technology and predictive analytics. With my team at Biofourmis, we have begun our journey towards unlocking the potential of biosensors to give deeper and meaningful insights into one’s health, through data. I seek to connect ideas and people to spark innovation.

What are your key business philosophies?

Firstly, delivering high quality products with real impact which increased patient safety, adherence and drives medical outcomes. Secondly, customers are the kings! The principles of respect, consideration, open communication and transparency his highly critical with clients. Thirdly, empowering employees think like owners, and lastly, thinking big. I want to revolutionise the healthcare ecosystem with the new version of quantitative medicine using personalised predictive analytics

Can you give us a glimpse of what you will talk about at the 20 Hottest Startups Panel Briefing 2017?

1. How biosensor technology is revolutionising the healthcare industry
2. The value of contextual data in health monitoring
3. Real-world continuous data with personalised predictive analytics to drive outcomes, real-word evidence and increase patient safety

In short, I’ll talk more about data analytics in the healthcare industry. With the explosion of wearable biosensors, there’s a tsunami of data being generated. It is how we leverage that data, make sense of these sensors and make it understandable and actionable to the healthcare community from payers, providers and people.

The SBR 20 Hottest Startups Panel Briefing will be on July 11 at the Meeting Room 3345, Suntec Singapore Convention & Exhibition Centre.

If you are interested to attend, you may contact Nikki Quiniquini at [email protected] or at +65 3158 1386 ext 238.